原发性肝癌放疗的指南推荐解读

doi:10.3760/cma.j.issn.1004-4221.2018.05.021

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract

The treatment guidelines based on evidence-based medical evidence provide appropriate treatment strategies for clinical oncologists. Currently, many treatment guidelines for primary liver cancer have been published and updated by many organizations from different countries, including Barcelona Clinic Liver Cancer (BCLC), European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL-EORTC), American Association for the Study of Liver Diseases (AASLD), National Comprehensive Cancer Network (NCCN), Asia-Pacific Primary Liver Cancer Expert (APPLE), Korean Liver Cancer Study Group and National Cancer Center (KLCSG-NCC), and Chinese Society for Therapeutic Radiology and Oncology (CSTRO), Chinese Medical Association. Although radiotherapy is commonly used in clinical practice, some guidelines do not accept it as a standard treatment strategy. In this article, we review the current treatment guidelines and discuss the current status and future prospects of radiotherapy in the management of primary liver cancer.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Yang Yongqiang
	Tian Ye

Key words： Liver neoplasms/radiotherapy Consensus

Received: 08 November 2017

Fund:

Suzhou “Revitalizing Healthcare with Science and Education” Youth Science and Technology Project (KJXW2016010);Jiangsu Medical Innovation Team (CXDT-37);Project of Suzhou Science and Technology Development Plan (SZS201509);Suzhou Clinical Medical Center Construction Project (Szzxj201503);Health Outstanding Leaders of Gusu (62)

Corresponding Authors: Tian Ye,Email:dryetian@126.com

Cite this article:

Yang Yongqiang,Tian Ye. A review of updated guidelines for radiotherapy for primary liver cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(5): 538-541.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2018.05.021 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2018/V27/I5/538

[1]Forner A,Reig ME,De Lope CR,et al. Current strategy for staging and treatment:the BCLC update and future prospects[J].Semin Liver Dis,2010,30(1):61-74.DOI:10.1055/s-0030-1247133.
[2]European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].Eur J Cancer,2012,48(5):599-641.DOI:10.1016/j.ejca.2011.12.021.
[3]Bruix J,Sherman M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020-1022.DOI:10.1002/hep.24199.
[4]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Hepatobiliary cancers[DB/OL].Fort Washington,PA:National Comprehensive Cancer Network[2018-02-14].https://www.nccn.org/professionals/physician_gls/default.aspx#site.
[5]Park HC,Yu JI,Cheng JCH,et al. Consensus for radiotherapy in hepatocellular carcinoma from the 5^th Asia-Pacific Primary Liver Cancer Expert meeting (APPLE 2014):current practice and future clinical trials[J].Liver Cancer,2016,5(3):162-174.DOI:10.1159/000367766.
[6]Korean Liver Cancer Study Group (KLCSG),National Cancer Center,Korea (NCC).2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma[J].Korean J Radiol,2015,16(3):465-522.DOI:10.3348/kjr.2015.16.3.465.
[7]中华医学会放射肿瘤学分会,中国生物医学工程学会精确放疗分会肝癌学组与消化系统肿瘤专家委员会,中国研究型医院学会放射肿瘤学分会肝癌学组.2016年原发性肝癌放疗共识[J].中华放射肿瘤学杂志,2016,25(11):1141-1150.DOI:10.3760/cma.j.issn.1004-4221.2016.11.001.
Radiation Oncology Branch of the Chinese Medical Association,Expert Committee on Liver Cancer and Digestive System of China Institute of Biomedical Engineering,Liver Cancer Research Group of Radiation Oncology Branch of China Research Hospital. Consensus on radiation therapy for primary liver cancer in 2016[J].Chin J Radiat Oncol,2016,25(11):1141-1150.DOI:10.3760/cma.j.issn.1004-4221.2016.11.001.
[8]Qi WX,Fu S,Zhang Q,et al. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma:a systematic review and meta-analysis[J].Radiother Oncol,2015,114(3):289-295.DOI:10.1016/j.radonc.2014.11.033.
[9]Im JH,Yoon SM,Park HC,et al. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area[J].Liver Int,2017,37(1):90-100.DOI:10.1111/liv.13191.
[10]Huo YR,Eslick GD.Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma:a systematic review and meta-analysis[J].JAMA Oncol,2015,1(6):756-765.DOI:10.1001/jamaoncol.2015.2189.
[11]Meng MB,Cui YL,Lu Y,et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma:a systematic review and meta-analysis[J].Radiother Oncol,2009,92(2):184-194.DOI:10.1016/j.radonc.2008.11.002.
[12]Zhang T,Zhao YT,Wang Z,et al. Efficacy and safety of intensity-modulated radiotherapy following transarterial chemoembolization in patients with unresectable hepatocellular carcinoma[J].Medicine,2016,95(21):e3789.DOI:10.1097/MD.0000000000003789.
[13]Hou JZ,Zeng ZC,Zhang JY,et al. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion[J].Int J Radiat Oncol Biol Phys,2012,84(2):362-368.DOI:10.1016/j.ijrobp.2011.12.024.
[14]Su TS,Liang P,Liang J,et al. Long-term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys,2017,98(3):639-646.DOI:10.1016/j.ijrobp.2017.02.095.
[15]Wang WH,Wang Z,Wu JX,et al. Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels[J].Liver Int,2015,35(12):2603-2610.DOI:10.1111/liv.12857.
[16]Llovet JM,Brú C,Bruix J.Prognosis of hepatocellular carcinoma:the BCLC staging classification[J].Semin Liver Dis,1999,19(3):329-338.DOI:10.1055/s-2007-1007122.
[17]Gomaa AI,Hashim MS,Waked I.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt[J].PLoS One,2014,9(3):e90929.DOI:10.1371/journal.pone.0090929.
[18]Zeng ZC,Seong J,Yoon SM,et al. Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7^th Asia-pacific primary liver cancer expert meeting[J].Liver Cancer,2017,6(4):264-274.DOI:10.1159/000475768.